These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34030495)

  • 41. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma.
    Nordfors C; Grün N; Tertipis N; Ährlund-Richter A; Haeggblom L; Sivars L; Du J; Nyberg T; Marklund L; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
    Eur J Cancer; 2013 Jul; 49(11):2522-30. PubMed ID: 23571147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.
    Gao G; Wang Z; Qu X; Zhang Z
    BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
    Liu S; Chen B; Burugu S; Leung S; Gao D; Virk S; Kos Z; Parulekar WR; Shepherd L; Gelmon KA; Nielsen TO
    JAMA Oncol; 2017 Nov; 3(11):e172085. PubMed ID: 28750133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An increase of CD8
    So YK; Byeon SJ; Ku BM; Ko YH; Ahn MJ; Son YI; Chung MK
    Sci Rep; 2020 Nov; 10(1):20059. PubMed ID: 33208791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of the density of tumor-infiltrating lymphocytes in colorectal cancer liver metastases.
    Wang E; Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Okazaki Y; Kashiwagi S; Tanaka H; Maeda K
    Oncol Lett; 2021 Dec; 22(6):837. PubMed ID: 34712361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A multicenter protocol to assess the prognostic significance of the tumor microenvironment in patients with squamous cell carcinoma of the larynx.
    De Luca P; Di Stadio A; Petruzzi G; de Campora L; Fior M; Moretti C; Della Peruta V; Mazzola F; Costarelli L; Covello R; Ricciardiello F; Tortoriello G; Pellini R; Radici M; Camaioni A
    Head Neck; 2024 Sep; 46(9):2123-2131. PubMed ID: 38958199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Value of Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma.
    Spector ME; Bellile E; Amlani L; Zarins K; Smith J; Brenner JC; Rozek L; Nguyen A; Thomas D; McHugh JB; Taylor JMG; Wolf GT;
    JAMA Otolaryngol Head Neck Surg; 2019 Nov; 145(11):1012-1019. PubMed ID: 31486841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of immune response with overall and disease-free survival in laryngeal squamous cell carcinomas.
    Bayrak AF; Eliyatkın NÖ; İşlek A; Özkul Y; Kılıç HS; Aktas S
    Am J Otolaryngol; 2022; 43(4):103477. PubMed ID: 35537231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor-Infiltrating Lymphocytes in the Tumor Microenvironment of Laryngeal Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.
    Rodrigo JP; Sánchez-Canteli M; López F; Wolf GT; Hernández-Prera JC; Williams MD; Willems SM; Franchi A; Coca-Pelaz A; Ferlito A
    Biomedicines; 2021 Apr; 9(5):. PubMed ID: 33925205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
    Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells.
    Duhen R; Ballesteros-Merino C; Frye AK; Tran E; Rajamanickam V; Chang SC; Koguchi Y; Bifulco CB; Bernard B; Leidner RS; Curti BD; Fox BA; Urba WJ; Bell RB; Weinberg AD
    Nat Commun; 2021 Feb; 12(1):1047. PubMed ID: 33594075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Prognostic Value of Sex-Determining Region Y-Box 2 and CD8+ Tumor-Infiltrating Lymphocytes in Limited-Stage Small-Cell Lung Cancer.
    Lee J; Jung YY; Lee JH; Hong M; Hwang HW; Hong SA; Hong SH
    Oncology; 2021; 99(8):528-538. PubMed ID: 34107469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A high ratio of IL-12Rβ2-positive tumor-infiltrating lymphocytes indicates favorable prognosis in laryngeal cancer.
    Tao Y; Gross N; Liu Y; Zhang L; Li G; Huang Z; Yang J
    Oral Oncol; 2017 Nov; 74():148-156. PubMed ID: 29103744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers.
    Xirou V; Moutafi M; Bai Y; Nwe Aung T; Burela S; Liu M; Kimple RJ; Shabbir Ahmed F; Schultz B; Flieder D; Connolly DC; Psyrri A; Burtness B; Rimm DL
    Oral Oncol; 2024 May; 152():106750. PubMed ID: 38547779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
    Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
    Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages.
    Kono-Sato T; Miyai K; Yamagishi Y; Miyamoto M; Takano M; Matsukuma S; Sato K; Tsuda H
    BMC Cancer; 2022 Apr; 22(1):361. PubMed ID: 35366828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Programmed death-ligand 1 expression and CD8+ tumor-infiltrating lymphocytes in advanced non-small cell lung cancer treated with microwave ablation and chemotherapy.
    Wei Z; Zhan X; Fan L; Ye X; Yang X; Huang G; Li W; Wang J; Han X; Meng M; Ni Y; Li Q
    Int J Hyperthermia; 2018; 35(1):591-598. PubMed ID: 30307348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
    Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
    Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy.
    Gataa I; Mezquita L; Rossoni C; Auclin E; Kossai M; Aboubakar F; Le Moulec S; Massé J; Masson M; Radosevic-Robin N; Alemany P; Rouanne M; Bluthgen V; Hendriks L; Caramella C; Gazzah A; Planchard D; Pignon JP; Besse B; Adam J
    Eur J Cancer; 2021 Mar; 145():221-229. PubMed ID: 33516050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pretreatment nutritional status, HPV infection, and tumor infiltrating lymphocyte as prognostic predictors in patients with head and neck squamous cell carcinoma after chemotherapy.
    Sutandyo N; Brahma B; Ifandriani R
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S177-S181. PubMed ID: 36510961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.